7275 ma exists, however, it is not well-investigated. Additionally, many of the studies were
conducted with small sample sizes, whereas biomarkers are ethnicity-dependent and …

Simple Summary Hepatocellular carcinoma (HCC) is the most common type of liver cancer,
accounting for approximately 85–90% of all cases of liver cancer worldwide. The gut …

Objective To characterise gut microbiome in patients with hepatocellular carcinoma (HCC)
and evaluate the potential of microbiome as non-invasive biomarkers for HCC. Design We …

Pancreatic cancer (PC) is a leading cause of cancer-related death in developed countries,
and since most patients have incurable disease at the time of diagnosis, developing a …

Oral, gut, and tumor microbiota have been implicated as important regulators in the
carcinogenesis and progression of gastrointestinal malignancies. However, few studies …

AIM To review microbiome alterations associated with pancreatic cancer, its potential utility
in diagnostics, risk assessment, and influence on disease outcomes. METHODS A …

Background Primary liver cancer has high mortality and morbidity worldwide. However, the
characteristic of gut microbiota profile and its correlation with inflammation status in liver …

Studying the effects of the microbiome on the development of different types of cancer has
recently received increasing research attention. In this context, the microbial content of …

The interaction between gut microbes and gastrointestinal (GI) tract carcinogenesis has
always attracted researchers' attention to identify therapeutic targets or potential prognostic …

Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality
worldwide. Increasing evidence indicates a close relationship between HCC and the human …